DrugOct 21, 2015
Ohm Laboratories Safeway Care Loratadine Orally Disintegrating Tablets, USP, 10 mg recall — FDA D-0034-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 288
10,690 detailed records are currently available in this category.
DrugOct 21, 2015
Ohm Laboratories TopCare LORATIDINE ORALLY DISINTEGRATING TABLETS, , USP, 10 mg recall — FDA D-0035-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Tribute Pharmaceuticals US Fenofibric Acid Tablets 105 mg recall — FDA D-0017-2016
Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.
Class IIIFDA: TerminatedTribute Pharmaceuticals US Inc.
DrugOct 21, 2015
The Mentholatum Co WellPatch Capsaicin Pain Relief Patch, 0.025% Natural Capsaicin, External recall — FDA D-0018-2016
Labeling: Incorrect Instructions; The word not is missing from the following sentences "do bandage tightly or cover with any type of wrap except clothing and "do use with a heating pad or…
Class IIFDA: TerminatedThe Mentholatum Co.
DrugOct 21, 2015
Ohm Laboratories Discount Drug Mart Food Fair, Original Prescription Strength, Loratadine recall — FDA D-0024-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Ohm Laboratories Wal-itin Loratadine Orally Disintegrating Tablets, USP, 10 mg recall — FDA D-0038-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Ferring Pharmaceuticals Bravelle 75 IU recall — FDA D-0015-2016
Subpotent Drug
Class IIIFDA: TerminatedFerring Pharmaceuticals Inc.
DrugOct 21, 2015
Ohm Laboratories CareOne Original Prescription Strength, Allergy Relief, Loratadine Orally recall — FDA D-0022-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Ohm Laboratories QC Quality Choice Loratadine Orally Disintegrating Tablets, USP 10 mg recall — FDA D-0019-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution recall — FDA D-0010-2016
Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
Class IIFDA: TerminatedNephron Pharmaceuticals Corp.
DrugOct 21, 2015
Tribute Pharmaceuticals US Fenofibric Acid Tablets, 35 mg, 30-count bottles, labeled as a) recall — FDA D-0016-2016
Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.
Class IIIFDA: TerminatedTribute Pharmaceuticals US Inc.
DrugOct 21, 2015
FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle recall — FDA D-0011-2016
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Class IIIFDA: TerminatedBoehringer Ingelheim Roxane Inc.
DrugOct 21, 2015
Ohm Laboratories Good Neighbor Pharmacy Loratadine Orally Disintegrating Tablets, USP, 10 mg recall — FDA D-0027-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Ohm Laboratories CVS Pharmacy, Original Prescription Strength, LORATADINE ORALLY recall — FDA D-0023-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Ohm Laboratories Rite Aid Pharmacy loratadine orally disintegrating tablets USP, 10 mg recall — FDA D-0020-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle recall — FDA D-0012-2016
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Class IIIFDA: TerminatedBoehringer Ingelheim Roxane Inc.
DrugOct 21, 2015
Actavis Laboratories, FL Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count recall — FDA D-0014-2016
Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.
Class IIFDA: TerminatedActavis Laboratories, FL, Inc.
DrugOct 21, 2015
Ohm Laboratories Equaline Original Prescription Strength, loratadine orally disintegrating recall — FDA D-0025-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 21, 2015
Midway Importing Sedalmex recall — FDA D-0013-2016
Cross Contamination With Other Products: Potential cross-contamination of cephalosporin.
Class IIFDA: TerminatedMidway Importing, Inc.
DrugOct 21, 2015
Ohm Laboratories Premier Value Loratadine Orally Disintegrating Tablets, USP, 10 mg recall — FDA D-0033-2016
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class IIIFDA: TerminatedOhm Laboratories, Inc.
DrugOct 14, 2015
Daytrana recall — FDA D-0008-2016
Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.
Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugOct 14, 2015
Diabetes Corporation of America dba DCA Pharmacy Sermorelin 6mg/6mL Lyophilized Powder recall — FDA D-0006-2016
Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility…
Class IIFDA: TerminatedDiabetes Corporation of America dba DCA Pharmacy
DrugOct 14, 2015
Merck Sharp & Dohme, Wilson Facility Vytorin recall — FDA D-0007-2016
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Class IIFDA: TerminatedMerck Sharp & Dohme, Wilson Facility
DrugOct 7, 2015
Guthy-Renker Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic recall — FDA D-0003-2016
Subpotent Drug: Salicylic acid is subpotent.
Class IIIFDA: TerminatedGuthy-Renker LLC
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.